{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:09:22Z","timestamp":1789006162191,"version":"build-2803163510"},"reference-count":218,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2022-NR067413"],"award-info":[{"award-number":["RS-2022-NR067413"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2026-25491139"],"award-info":[{"award-number":["RS-2026-25491139"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2026-25480185"],"award-info":[{"award-number":["RS-2026-25480185"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04715-5","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:06:15Z","timestamp":1782428775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multistage nanomedicine engineering to overcome sequential barriers to glioblastoma treatment: a review"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8671-473X","authenticated-orcid":false,"given":"Gayeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2353-8017","authenticated-orcid":false,"given":"Dongwoo","family":"Khang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"8","key":"4715_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231\u201351.","journal-title":"Neuro Oncol"},{"issue":"7","key":"4715_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329(7):574\u201387.","journal-title":"JAMA"},{"issue":"10","key":"4715_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396.","journal-title":"N Engl J Med"},{"key":"4715_CR4","doi-asserted-by":"publisher","unstructured":"Sadowski K, Jazdzewska A, Kozlowski J, Zacny A, Lorenc T, Olejarz W. Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches. Int J Mol Sci. 2024;25(11):5774. https:\/\/doi.org\/10.3390\/ijms25115774","DOI":"10.3390\/ijms25115774"},{"key":"4715_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010351","author":"A Ou","year":"2020","unstructured":"Ou A, Yung WKA, Majd N. Molecular Mechanisms of Treatment Resistance in Glioblastoma. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms22010351.","journal-title":"Int J Mol Sci"},{"key":"4715_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032496","author":"F Roda","year":"2023","unstructured":"Roda F, Caraffi R, Picciolini S, Tosi G, Vandelli MA, Ruozi B, et al. Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032496.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4715_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.trecan.2015.10.009","volume":"1","author":"D Hambardzumyan","year":"2015","unstructured":"Hambardzumyan D, Bergers G. Glioblastoma: defining tumor niches. Trends Cancer. 2015;1(4):252\u201365.","journal-title":"Trends Cancer"},{"issue":"5","key":"4715_CR8","doi-asserted-by":"publisher","first-page":"e14715","DOI":"10.1111\/cns.14715","volume":"30","author":"J Liu","year":"2024","unstructured":"Liu J, Yang F, Hu J, Zhang X. Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives. CNS Neurosci Ther. 2024;30(5):e14715.","journal-title":"CNS Neurosci Ther"},{"issue":"11","key":"4715_CR9","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1039\/C8CS00805A","volume":"48","author":"W Tang","year":"2019","unstructured":"Tang W, Fan W, Lau J, Deng L, Shen Z, Chen X. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics. Chem Soc Rev. 2019;48(11):2967\u20133014.","journal-title":"Chem Soc Rev"},{"issue":"5","key":"4715_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2016.14","volume":"1","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm S, Tavares AJ, Dai Q, Ohta S, Audet J, Dvorak HF, et al. Analysis of nanoparticle delivery to tumours. Nature Reviews Materials. 2016;1(5):16014.","journal-title":"Nature Reviews Materials"},{"key":"4715_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-024-06104-1","author":"KN Panchal","year":"2024","unstructured":"Panchal KN, Mutalik S, Manikkath J. Biomimetic nanoparticle-driven strategies for targeted drug delivery in glioblastoma. J Nanopart Res. 2024. https:\/\/doi.org\/10.1007\/s11051-024-06104-1.","journal-title":"J Nanopart Res"},{"issue":"2","key":"4715_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101\u201324.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"4715_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8(1):217.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4715_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17(1):69.","journal-title":"Fluids Barriers CNS"},{"key":"4715_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102391","author":"F Marcucci","year":"2021","unstructured":"Marcucci F, Corti A, Ferreri AJM. Breaching the Blood-Brain Tumor Barrier for Tumor Therapy. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13102391.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"4715_CR16","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32(11):1959\u201372.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"4715_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/neuonc\/nox175","volume":"20","author":"JN Sarkaria","year":"2018","unstructured":"Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN, et al. Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Neuro Oncol. 2018;20(2):184\u201391.","journal-title":"Neuro Oncol"},{"issue":"3","key":"4715_CR18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00441-014-1811-2","volume":"355","author":"B Engelhardt","year":"2014","unstructured":"Engelhardt B, Liebner S. Novel insights into the development and maintenance of the blood-brain barrier. Cell Tissue Res. 2014;355(3):687\u201399.","journal-title":"Cell Tissue Res"},{"key":"4715_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/VIW.20200129","author":"Y Song","year":"2022","unstructured":"Song Y, Hu C, Fu Y, Gao H. Modulating the blood\u2013brain tumor barrier for improving drug delivery efficiency and efficacy. View. 2022. https:\/\/doi.org\/10.1002\/VIW.20200129.","journal-title":"View"},{"key":"4715_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061879","author":"S Marino","year":"2023","unstructured":"Marino S, Menna G, Di Bonaventura R, Lisi L, Mattogno P, Figa F, et al. The Extracellular Matrix in Glioblastomas: A Glance at Its Structural Modifications in Shaping the Tumoral Microenvironment-A Systematic Review. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15061879.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4715_CR21","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1186\/s12885-024-12751-3","volume":"24","author":"R Wei","year":"2024","unstructured":"Wei R, Zhou J, Bui B, Liu X. Glioma actively orchestrate a self-advantageous extracellular matrix to promote recurrence and progression. BMC Cancer. 2024;24(1):974.","journal-title":"BMC Cancer"},{"issue":"8","key":"4715_CR22","first-page":"3742","volume":"11","author":"E Mohiuddin","year":"2021","unstructured":"Mohiuddin E, Wakimoto H. Extracellular matrix in glioblastoma: opportunities for emerging therapeutic approaches. Am J Cancer Res. 2021;11(8):3742\u201354.","journal-title":"Am J Cancer Res"},{"key":"4715_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201700739","author":"L Tomasetti","year":"2018","unstructured":"Tomasetti L, Breunig M. Preventing Obstructions of Nanosized Drug Delivery Systems by the Extracellular Matrix. Adv Healthc Mater. 2018. https:\/\/doi.org\/10.1002\/adhm.201700739.","journal-title":"Adv Healthc Mater"},{"key":"4715_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jtbi.2012.11.031","volume":"320","author":"M Wu","year":"2013","unstructured":"Wu M, Frieboes HB, McDougall SR, Chaplain MA, Cristini V, Lowengrub J. The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems. J Theor Biol. 2013;320:131\u201351.","journal-title":"J Theor Biol"},{"issue":"Suppl 5","key":"4715_CR25","doi-asserted-by":"publisher","first-page":"v161","DOI":"10.1093\/neuonc\/nou265.11","volume":"16","author":"S Ilkhanizadeh","year":"2014","unstructured":"Ilkhanizadeh S, Miroshnikova Y, Frantz A, James D, Berger M, McKnight T, et al. NT-11: TARGETING INTERSTITIAL FLUID PRESSURE TO REDUCE TUMOR GROWTH AND INCREASE DRUG UPTAKE IN BRAIN TUMORS. Neuro Oncol. 2014;16(Suppl 5):v161.","journal-title":"Neuro Oncol"},{"key":"4715_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fonc.2015.00165","volume":"5","author":"G Baronzio","year":"2015","unstructured":"Baronzio G, Parmar G, Baronzio M. Overview of methods for overcoming hindrance to drug delivery to tumors, with special attention to tumor interstitial fluid. Front Oncol. 2015;5:165.","journal-title":"Front Oncol"},{"issue":"2","key":"4715_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1215\/S1152851704001115","volume":"7","author":"B Kaur","year":"2005","unstructured":"Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol. 2005;7(2):134\u201353.","journal-title":"Neuro Oncol"},{"key":"4715_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115518","author":"AM Reuss","year":"2021","unstructured":"Reuss AM, Groos D, Buchfelder M, Savaskan N. The Acidic Brain-Glycolytic Switch in the Microenvironment of Malignant Glioma. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22115518.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4715_CR29","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1582-4934.2009.00994.x","volume":"14","author":"J Chiche","year":"2010","unstructured":"Chiche J, Brahimi-Horn MC, Pouyssegur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med. 2010;14(4):771\u201394.","journal-title":"J Cell Mol Med"},{"key":"4715_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.620677","volume":"7","author":"C Olivier","year":"2020","unstructured":"Olivier C, Oliver L, Lalier L, Vallette FM. Drug resistance in glioblastoma: the two faces of oxidative stress. Frontiers in Molecular Biosciences. 2020;7:620677.","journal-title":"Frontiers in Molecular Biosciences"},{"key":"4715_CR31","doi-asserted-by":"publisher","first-page":"101578","DOI":"10.1016\/j.redox.2020.101578","volume":"34","author":"K Lei","year":"2020","unstructured":"Lei K, Xia Y, Wang XC, Ahn EH, Jin L, Ye K. C\/EBPbeta mediates NQO1 and GSTP1 anti-oxidative reductases expression in glioblastoma, promoting brain tumor proliferation. Redox Biol. 2020;34:101578.","journal-title":"Redox Biol"},{"issue":"2","key":"4715_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188428","volume":"1874","author":"A Quesnel","year":"2020","unstructured":"Quesnel A, Karagiannis GS, Filippou PS. Extracellular proteolysis in glioblastoma progression and therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2020;1874(2):188428.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"5","key":"4715_CR33","doi-asserted-by":"publisher","first-page":"e1893","DOI":"10.1002\/wnan.1893","volume":"15","author":"C Martins","year":"2023","unstructured":"Martins C, Sarmento B. Multi-ligand functionalized blood-to-tumor sequential targeting strategies in the field of glioblastoma nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15(5):e1893.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"1","key":"4715_CR34","first-page":"26","volume":"4","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wang S, Cheng G, Yu P, Chang J, Chen X. Cascade Drug-Release Strategy for Enhanced Anticancer Therapy. Matter (Cambridge, Mass). 2021;4(1):26\u201353.","journal-title":"Matter (Cambridge, Mass)"},{"key":"4715_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112346","author":"W Zhou","year":"2022","unstructured":"Zhou W, Jia Y, Liu Y, Chen Y, Zhao P. Tumor microenvironment-based stimuli-responsive nanoparticles for controlled release of drugs in cancer therapy. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14112346.","journal-title":"Pharmaceutics"},{"issue":"22","key":"4715_CR36","doi-asserted-by":"publisher","first-page":"14145","DOI":"10.1021\/acsnano.3c03409","volume":"18","author":"P Dosta","year":"2024","unstructured":"Dosta P, Dion MZ, Prado M, Hurtado P, Riojas-Javelly CJ, Cryer AM, et al. Matrix Metalloproteinase- and pH-Sensitive Nanoparticle System Enhances Drug Retention and Penetration in Glioblastoma. ACS Nano. 2024;18(22):14145\u201360.","journal-title":"ACS Nano"},{"key":"4715_CR37","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.2147\/IJN.S450853","volume":"19","author":"SH Lim","year":"2024","unstructured":"Lim SH, Yee GT, Khang D. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier. Int J Nanomed. 2024;19:2529\u201352.","journal-title":"Int J Nanomed"},{"issue":"3","key":"4715_CR38","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","volume":"18","author":"S Zha","year":"2024","unstructured":"Zha S, Liu H, Li H, Li H, Wong KL, All AH. Functionalized Nanomaterials Capable of Crossing the Blood-Brain Barrier. ACS Nano. 2024;18(3):1820\u201345.","journal-title":"ACS Nano"},{"key":"4715_CR39","doi-asserted-by":"publisher","first-page":"213125","DOI":"10.1016\/j.bioadv.2022.213125","volume":"141","author":"SL van den Broek","year":"2022","unstructured":"van den Broek SL, Shalgunov V, Herth MM. Transport of nanomedicines across the blood-brain barrier: Challenges and opportunities for imaging and therapy. Biomater Adv. 2022;141:213125.","journal-title":"Biomater Adv"},{"key":"4715_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2024.1360302","author":"AS Haqqani","year":"2024","unstructured":"Haqqani AS, B\u00e9langer K, Stanimirovic DB. Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria. Frontiers in Drug Delivery. 2024. https:\/\/doi.org\/10.3389\/fddev.2024.1360302.","journal-title":"Frontiers in Drug Delivery"},{"issue":"11","key":"4715_CR41","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1021\/acs.molpharmaceut.5b00597","volume":"12","author":"I Cabezon","year":"2015","unstructured":"Cabezon I, Manich G, Martin-Venegas R, Camins A, Pelegri C, Vilaplana J. Trafficking of Gold Nanoparticles Coated with the 8D3 Anti-Transferrin Receptor Antibody at the Mouse Blood-Brain Barrier. Mol Pharm. 2015;12(11):4137\u201345.","journal-title":"Mol Pharm"},{"issue":"4","key":"4715_CR42","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1248\/cpb.c19-00854","volume":"68","author":"T Tashima","year":"2020","unstructured":"Tashima T. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis. Chem Pharm Bull (Tokyo). 2020;68(4):316\u201325.","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"5","key":"4715_CR43","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1021\/acsabm.8b00502","volume":"1","author":"Q Lu","year":"2018","unstructured":"Lu Q, Cai X, Zhang X, Li S, Song Y, Du D, et al. Synthetic Polymer Nanoparticles Functionalized with Different Ligands for Receptor-mediated Transcytosis across Blood-Brain Barrier. ACS Appl Bio Mater. 2018;1(5):1687\u201394.","journal-title":"ACS Appl Bio Mater"},{"issue":"2","key":"4715_CR44","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","volume":"25","author":"EL Han","year":"2025","unstructured":"Han EL, Tang S, Kim D, Murray AM, Swingle KL, Hamilton AG, et al. Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain. Nano Lett. 2025;25(2):800\u201310.","journal-title":"Nano Lett"},{"issue":"1","key":"4715_CR45","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1021\/acsnano.4c05906","volume":"19","author":"JL Meng","year":"2025","unstructured":"Meng JL, Dong ZX, Chen YR, Lin MH, Liu YC, Roffler SR, et al. pH-Responsive Polyethylene Glycol Engagers for Enhanced Brain Delivery of PEGylated Nanomedicine to Treat Glioblastoma. ACS Nano. 2025;19(1):307\u201321.","journal-title":"ACS Nano"},{"issue":"3","key":"4715_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","volume":"10","author":"F Herve","year":"2008","unstructured":"Herve F, Ghinea N, Scherrmann JM. CNS delivery via adsorptive transcytosis. AAPS J. 2008;10(3):455\u201372.","journal-title":"AAPS J"},{"issue":"12","key":"4715_CR47","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1021\/acs.biomac.1c01109","volume":"22","author":"S Chen","year":"2021","unstructured":"Chen S, Zhou Q, Wang G, Zhou Z, Tang J, Xie T, et al. Effect of Cationic Charge Density on Transcytosis of Polyethylenimine. Biomacromolecules. 2021;22(12):5139\u201350.","journal-title":"Biomacromolecules"},{"issue":"4","key":"4715_CR48","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.biomaterials.2012.09.047","volume":"34","author":"JY Kim","year":"2013","unstructured":"Kim JY, Choi WI, Kim YH, Tae G. Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier. Biomaterials. 2013;34(4):1170\u20138.","journal-title":"Biomaterials"},{"key":"4715_CR49","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.2147\/IJN.S215941","volume":"14","author":"B Dos Santos Rodrigues","year":"2019","unstructured":"Dos Santos Rodrigues B, Lakkadwala S, Kanekiyo T, Singh J. Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties. Int J Nanomed. 2019;14:6497\u2013517.","journal-title":"Int J Nanomed"},{"key":"4715_CR50","doi-asserted-by":"publisher","first-page":"113983","DOI":"10.1016\/j.colsurfb.2024.113983","volume":"241","author":"M Mendes","year":"2024","unstructured":"Mendes M, Nunes S, Cova T, Branco F, Dyrks M, Koksch B, et al. Charge-switchable cell-penetrating peptides for rerouting nanoparticles to glioblastoma treatment. Colloids Surf B Biointerfaces. 2024;241:113983.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"2","key":"4715_CR51","doi-asserted-by":"publisher","first-page":"151406","DOI":"10.1016\/j.ejcb.2024.151406","volume":"103","author":"M Kurtyka","year":"2024","unstructured":"Kurtyka M, Wessely F, Bau S, Ifie E, He L, de Wit NM, et al. The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier. Eur J Cell Biol. 2024;103(2):151406.","journal-title":"Eur J Cell Biol"},{"key":"4715_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00973","volume":"11","author":"R Zaragoza","year":"2020","unstructured":"Zaragoza R. Transport of Amino Acids Across the Blood-Brain Barrier. Front Physiol. 2020;11:973.","journal-title":"Front Physiol"},{"issue":"3","key":"4715_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/15216540214541","volume":"54","author":"RA Hawkins","year":"2002","unstructured":"Hawkins RA, Peterson DR, Vina JR. The complementary membranes forming the blood-brain barrier. IUBMB Life. 2002;54(3):101\u20137.","journal-title":"IUBMB Life"},{"key":"4715_CR54","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejps.2018.07.042","volume":"123","author":"M Meszaros","year":"2018","unstructured":"Meszaros M, Porkolab G, Kiss L, Pilbat AM, Kota Z, Kupihar Z, et al. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier. Eur J Pharm Sci. 2018;123:228\u201340.","journal-title":"Eur J Pharm Sci"},{"key":"4715_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010086","author":"S Veszelka","year":"2021","unstructured":"Veszelka S, Meszaros M, Porkolab G, Szecsko A, Kondor N, Ferenc G, et al. A triple combination of targeting ligands increases the penetration of nanoparticles across a blood-brain barrier culture model. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics14010086.","journal-title":"Pharmaceutics"},{"issue":"2","key":"4715_CR56","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s12035-015-9672-6","volume":"54","author":"SG Patching","year":"2017","unstructured":"Patching SG. Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery. Mol Neurobiol. 2017;54(2):1046\u201377.","journal-title":"Mol Neurobiol"},{"issue":"8","key":"4715_CR57","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1517\/14728222.2015.1042364","volume":"19","author":"WM Pardridge","year":"2015","unstructured":"Pardridge WM. Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery. Expert Opin Ther Targets. 2015;19(8):1059\u201372.","journal-title":"Expert Opin Ther Targets"},{"issue":"1 Suppl","key":"4715_CR58","doi-asserted-by":"publisher","first-page":"S218","DOI":"10.1093\/jn\/136.1.218S","volume":"136","author":"RA Hawkins","year":"2006","unstructured":"Hawkins RA, O\u2019Kane RL, Simpson IA, Vina JR. Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr. 2006;136(1 Suppl):S218\u201326.","journal-title":"J Nutr"},{"issue":"6","key":"4715_CR59","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","volume":"27","author":"EG Knox","year":"2022","unstructured":"Knox EG, Aburto MR, Clarke G, Cryan JF, O\u2019Driscoll CM. The blood-brain barrier in aging and neurodegeneration. Mol Psychiatry. 2022;27(6):2659\u201373.","journal-title":"Mol Psychiatry"},{"issue":"7","key":"4715_CR60","doi-asserted-by":"publisher","first-page":"7292","DOI":"10.1021\/acsnano.8b03500","volume":"12","author":"A Cox","year":"2018","unstructured":"Cox A, Andreozzi P, Dal Magro R, Fiordaliso F, Corbelli A, Talamini L, et al. Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier. ACS Nano. 2018;12(7):7292\u2013300.","journal-title":"ACS Nano"},{"issue":"2","key":"4715_CR61","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2217\/nnm.14.69","volume":"10","author":"M Mahmoudi","year":"2015","unstructured":"Mahmoudi M, Sheibani S, Milani AS, Rezaee F, Gauberti M, Dinarvand R, et al. Crucial role of the protein corona for the specific targeting of nanoparticles. Nanomed (Lond). 2015;10(2):215\u201326.","journal-title":"Nanomed (Lond)"},{"issue":"2","key":"4715_CR62","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nnano.2012.237","volume":"8","author":"A Salvati","year":"2013","unstructured":"Salvati A, Pitek AS, Monopoli MP, Prapainop K, Bombelli FB, Hristov DR, et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol. 2013;8(2):137\u201343.","journal-title":"Nat Nanotechnol"},{"key":"4715_CR63","doi-asserted-by":"publisher","first-page":"120888","DOI":"10.1016\/j.biomaterials.2021.120888","volume":"274","author":"W Xiao","year":"2021","unstructured":"Xiao W, Wang Y, Zhang H, Liu Y, Xie R, He X, et al. The protein corona hampers the transcytosis of transferrin-modified nanoparticles through blood-brain barrier and attenuates their targeting ability to brain tumor. Biomaterials. 2021;274:120888.","journal-title":"Biomaterials"},{"issue":"20","key":"4715_CR64","doi-asserted-by":"publisher","first-page":"12716","DOI":"10.1021\/acsnano.3c08993","volume":"18","author":"ZA Chen","year":"2024","unstructured":"Chen ZA, Wu CH, Wu SH, Huang CY, Mou CY, Wei KC, et al. Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood-Brain Barrier. ACS Nano. 2024;18(20):12716\u201336.","journal-title":"ACS Nano"},{"issue":"32","key":"4715_CR65","doi-asserted-by":"publisher","first-page":"11118","DOI":"10.1021\/acs.analchem.2c02501","volume":"94","author":"Y Yu","year":"2022","unstructured":"Yu Y, Wang M, Li M, Zhang L, Zhao J, Cao J, et al. Controlled Recognition and Corona Formation by Cascade Micellar Nanoprobes: for Boosting Glioma Theranostics. Anal Chem. 2022;94(32):11118\u201323.","journal-title":"Anal Chem"},{"key":"4715_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115114","volume":"202","author":"K Jiang","year":"2023","unstructured":"Jiang K, Yu Y, Qiu W, Tian K, Guo Z, Qian J, et al. Protein corona on brain targeted nanocarriers: challenges and prospects. Advanced Drug Delivery Reviews. 2023;202:115114.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"4715_CR67","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jconrel.2024.12.066","volume":"378","author":"M Zhao","year":"2025","unstructured":"Zhao M, Lin Y, Zeng Y, Lv Z, Liang J, Tang P, et al. Biomimetic membrane-coated nanoparticles specially permeate the inflammatory blood-brain barrier to deliver plasmin therapy for brain metastases. J Control Release. 2025;378:763\u201375.","journal-title":"J Control Release"},{"issue":"8","key":"4715_CR68","doi-asserted-by":"publisher","first-page":"e2200289","DOI":"10.1002\/smtd.202200289","volume":"6","author":"J Lopes","year":"2022","unstructured":"Lopes J, Lopes D, Pereira-Silva M, Peixoto D, Veiga F, Hamblin MR, et al. Macrophage Cell Membrane-Cloaked Nanoplatforms for Biomedical Applications. Small Methods. 2022;6(8):e2200289.","journal-title":"Small Methods"},{"issue":"44","key":"4715_CR69","doi-asserted-by":"publisher","first-page":"e2301439","DOI":"10.1002\/smll.202301439","volume":"19","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhang Y, Wang X, Zhou Y, Qi J, Gu L, et al. A Trojan-Horse-Like Biomimetic Nano-NK to Elicit an Immunostimulatory Tumor Microenvironment for Enhanced GBM Chemo-Immunotherapy. Small. 2023;19(44):e2301439.","journal-title":"Small"},{"issue":"29","key":"4715_CR70","doi-asserted-by":"publisher","first-page":"e2306714","DOI":"10.1002\/smll.202306714","volume":"20","author":"H Chen","year":"2024","unstructured":"Chen H, Ji J, Zhang L, Luo C, Chen T, Zhang Y, et al. Nanoparticles Coated with Brain Microvascular Endothelial Cell Membranes can Target and Cross the Blood-Brain Barrier to Deliver Drugs to Brain Tumors. Small. 2024;20(29):e2306714.","journal-title":"Small"},{"issue":"1","key":"4715_CR71","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1038\/s41467-022-33889-3","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu L, Pan D, Chen S, Martikainen MV, Karlund A, Ke J, et al. Systematic design of cell membrane coating to improve tumor targeting of nanoparticles. Nat Commun. 2022;13(1):6181.","journal-title":"Nat Commun"},{"issue":"1","key":"4715_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.biocel.2011.10.005","volume":"44","author":"AK Ludwig","year":"2012","unstructured":"Ludwig AK, Giebel B. Exosomes: small vesicles participating in intercellular communication. Int J Biochem Cell Biol. 2012;44(1):11\u20135.","journal-title":"Int J Biochem Cell Biol"},{"key":"4715_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/biology11060804","author":"MA Di Bella","year":"2022","unstructured":"Di Bella MA. Overview and update on extracellular vesicles: considerations on exosomes and their application in modern medicine. Biology. 2022. https:\/\/doi.org\/10.3390\/biology11060804.","journal-title":"Biology"},{"key":"4715_CR74","doi-asserted-by":"publisher","first-page":"114298","DOI":"10.1016\/j.ejpb.2024.114298","volume":"199","author":"K Yadav","year":"2024","unstructured":"Yadav K, Vijayalakshmi R, Kumar Sahu K, Sure P, Chahal K, Yadav R, et al. Exosome-Based Macromolecular neurotherapeutic drug delivery approaches in overcoming the Blood-Brain barrier for treating brain disorders. Eur J Pharm Biopharm. 2024;199:114298.","journal-title":"Eur J Pharm Biopharm"},{"key":"4715_CR75","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/ace39c","author":"J Wang","year":"2023","unstructured":"Wang J, Yang L. The role of exosomes in central nervous system tissue regeneration and repair. Biomed Mater. 2023. https:\/\/doi.org\/10.1088\/1748-605X\/ace39c.","journal-title":"Biomed Mater"},{"issue":"11","key":"4715_CR76","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov R, Sasso JM, Wang X, Liaw WS, Chen CA, Zhou QA. Exosomes horizontal line Nature\u2019s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics. ACS Nano. 2022;16(11):17802\u201346.","journal-title":"ACS Nano"},{"issue":"40","key":"4715_CR77","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.2174\/1381612823666170913164738","volume":"23","author":"J Matsumoto","year":"2017","unstructured":"Matsumoto J, Stewart T, Banks WA, Zhang J. The Transport Mechanism of Extracellular Vesicles at the Blood-Brain Barrier. Curr Pharm Des. 2017;23(40):6206\u201314.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"4715_CR78","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12987-025-00646-9","volume":"22","author":"HL Denis","year":"2025","unstructured":"Denis HL, de Rus Jacquet A, Alpaugh M, Panisset M, Barker RA, Boilard E, et al. Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson\u2019s disease-like neurodegeneration. Fluids Barriers CNS. 2025;22(1):38.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"4715_CR79","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s42003-023-04859-2","volume":"6","author":"CL Alter","year":"2023","unstructured":"Alter CL, Detampel P, Schefer RB, Lotter C, Hauswirth P, Puligilla RD, et al. High efficiency preparation of monodisperse plasma membrane derived extracellular vesicles for therapeutic applications. Commun Biol. 2023;6(1):478.","journal-title":"Commun Biol"},{"key":"4715_CR80","doi-asserted-by":"publisher","first-page":"22519","DOI":"10.1038\/srep22519","volume":"6","author":"E Willms","year":"2016","unstructured":"Willms E, Johansson HJ, Mager I, Lee Y, Blomberg KE, Sadik M, et al. Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep. 2016;6:22519.","journal-title":"Sci Rep"},{"key":"4715_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030672","author":"H Choi","year":"2022","unstructured":"Choi H, Choi K, Kim DH, Oh BK, Yim H, Jo S, et al. Strategies for targeted delivery of exosomes to the brain: advantages and challenges. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14030672.","journal-title":"Pharmaceutics"},{"key":"4715_CR82","doi-asserted-by":"publisher","first-page":"11767","DOI":"10.2147\/IJN.S496028","volume":"19","author":"YG Jeong","year":"2024","unstructured":"Jeong YG, Park JH, Khang D. Sonodynamic and Acoustically Responsive Nanodrug Delivery System: Cancer Application. Int J Nanomed. 2024;19:11767\u201388.","journal-title":"Int J Nanomed"},{"issue":"10","key":"4715_CR83","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1364\/BOE.9.004850","volume":"9","author":"C Zhang","year":"2018","unstructured":"Zhang C, Feng W, Vodovozova E, Tretiakova D, Boldyrevd I, Li Y, et al. Photodynamic opening of the blood-brain barrier to high weight molecules and liposomes through an optical clearing skull window. Biomed Opt Express. 2018;9(10):4850\u201362.","journal-title":"Biomed Opt Express"},{"key":"4715_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13071084","author":"KT Chen","year":"2021","unstructured":"Chen KT, Wei KC, Liu HL. Focused ultrasound combined with microbubbles in central nervous system applications. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13071084.","journal-title":"Pharmaceutics"},{"issue":"2","key":"4715_CR85","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.biomaterials.2011.09.096","volume":"33","author":"CY Ting","year":"2012","unstructured":"Ting CY, Fan CH, Liu HL, Huang CY, Hsieh HY, Yen TC, et al. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Biomaterials. 2012;33(2):704\u201312.","journal-title":"Biomaterials"},{"issue":"52","key":"4715_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202308150","volume":"35","author":"A Dasgupta","year":"2023","unstructured":"Dasgupta A, Sun T, Rama E, Motta A, Zhang Y, Power C, et al. Transferrin Receptor-Targeted Nonspherical Microbubbles for Blood-Brain Barrier Sonopermeation. Adv Mater. 2023;35(52):e2308150.","journal-title":"Adv Mater"},{"key":"4715_CR87","doi-asserted-by":"publisher","first-page":"117762","DOI":"10.1016\/j.biopha.2024.117762","volume":"182","author":"C Angolano","year":"2025","unstructured":"Angolano C, Hansen E, Ajjawi H, Nowlin P, Zhang Y, Thunemann N, et al. Characterization of focused ultrasound blood-brain barrier disruption effect on inflammation as a function of treatment parameters. Biomed Pharmacother. 2025;182:117762.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"4715_CR88","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1177\/0271678X17753514","volume":"39","author":"HA Kamimura","year":"2019","unstructured":"Kamimura HA, Flament J, Valette J, Cafarelli A, Aron Badin R, Hantraye P, et al. Feedback control of microbubble cavitation for ultrasound-mediated blood-brain barrier disruption in non-human primates under magnetic resonance guidance. J Cereb Blood Flow Metab. 2019;39(7):1191\u2013203.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"4715_CR89","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/lsm.23075","volume":"51","author":"C Zhang","year":"2019","unstructured":"Zhang C, Feng W, Li Y, Kurths J, Yu T, Semyachkina-Glushkovskaya O, et al. Age differences in photodynamic therapy-mediated opening of the blood-brain barrier through the optical clearing skull window in mice. Lasers Surg Med. 2019;51(7):625\u201333.","journal-title":"Lasers Surg Med"},{"key":"4715_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/app10010033","author":"O Semyachkina-Glushkovskaya","year":"2019","unstructured":"Semyachkina-Glushkovskaya O, Borisova E, Mantareva V, Angelov I, Eneva I, Terskov A, et al. Photodynamic opening of the blood\u2013brain barrier using different photosensitizers in mice. Applied Sciences. 2019. https:\/\/doi.org\/10.3390\/app10010033.","journal-title":"Applied Sciences"},{"key":"4715_CR91","doi-asserted-by":"publisher","first-page":"11023","DOI":"10.2147\/IJN.S486014","volume":"19","author":"SS Rajan","year":"2024","unstructured":"Rajan SS, Chandran R, Abrahamse H. Advancing photodynamic therapy with nano-conjugated hypocrellin: mechanisms and clinical applications. Int J Nanomedicine. 2024;19:11023\u201338.","journal-title":"Int J Nanomedicine"},{"key":"4715_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104272","author":"Y Shu","year":"2023","unstructured":"Shu Y, Linghu X, Zhao Y, Chen Z, Zhang J, Shan D, et al. Photodynamic and photothermal therapy-driven synergistic cancer treatment assisted by zeolitic imidazolate framework-8: a review. Journal of Drug Delivery Science and Technology. 2023. https:\/\/doi.org\/10.1016\/j.jddst.2023.104272.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"4715_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133427","author":"D Bhanja","year":"2023","unstructured":"Bhanja D, Wilding H, Baroz A, Trifoi M, Shenoy G, Slagle-Webb B, et al. Photodynamic Therapy for Glioblastoma: Illuminating the Path toward Clinical Applicability. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15133427.","journal-title":"Cancers (Basel)"},{"key":"4715_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2019.122693","author":"X Wang","year":"2020","unstructured":"Wang X, Li Z, Ding Y, Wang K, Xing Z, Sun X, et al. Enhanced photothermal-photodynamic therapy for glioma based on near-infrared dye functionalized Fe3O4 superparticles. Chem Eng J. 2020. https:\/\/doi.org\/10.1016\/j.cej.2019.122693.","journal-title":"Chem Eng J"},{"key":"4715_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.791709","volume":"15","author":"SR Rodriguez-Masso","year":"2021","unstructured":"Rodriguez-Masso SR, Erickson MA, Banks WA, Ulrich H, Martins AH. The bradykinin B2 receptor agonist (NG291) causes rapid onset of transient blood-brain barrier disruption without evidence of early brain injury. Front Neurosci. 2021;15:791709.","journal-title":"Front Neurosci"},{"issue":"3","key":"4715_CR96","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1021\/mp400624v","volume":"11","author":"NH On","year":"2014","unstructured":"On NH, Kiptoo P, Siahaan TJ, Miller DW. Modulation of blood-brain barrier permeability in mice using synthetic E-cadherin peptide. Mol Pharm. 2014;11(3):974\u201381.","journal-title":"Mol Pharm"},{"key":"4715_CR97","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1073\/pnas.2021915118","volume":"118","author":"SR Burks","year":"2021","unstructured":"Burks SR, Kersch CN, Witko JA, Pagel MA, Sundby M, Muldoon LL, et al. Blood-brain barrier opening by intracarotid artery hyperosmolar mannitol induces sterile inflammatory and innate immune responses. Proc Natl Acad Sci U S A. 2021;118:18.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4715_CR98","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12987-017-0088-8","volume":"15","author":"S Jackson","year":"2018","unstructured":"Jackson S, Weingart J, Nduom EK, Harfi TT, George RT, McAreavey D, et al. The effect of an adenosine A(2A) agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma. Fluids Barriers CNS. 2018;15(1):2.","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"4715_CR99","doi-asserted-by":"publisher","first-page":"eadq2616","DOI":"10.1126\/sciadv.adq2616","volume":"11","author":"M Trevisani","year":"2025","unstructured":"Trevisani M, Berselli A, Alberini G, Centonze E, Vercellino S, Cartocci V, et al. A claudin5-binding peptide enhances the permeability of the blood-brain barrier in vitro. Sci Adv. 2025;11(2):eadq2616.","journal-title":"Sci Adv"},{"issue":"9","key":"4715_CR100","doi-asserted-by":"publisher","first-page":"eadr1481","DOI":"10.1126\/sciadv.adr1481","volume":"11","author":"JL Jimenez-Macias","year":"2025","unstructured":"Jimenez-Macias JL, Vaughn-Beaucaire P, Bharati A, Xu Z, Forrest M, Hong J, et al. Modulation of blood-tumor barrier transcriptional programs improves intratumoral drug delivery and potentiates chemotherapy in GBM. Sci Adv. 2025;11(9):eadr1481.","journal-title":"Sci Adv"},{"key":"4715_CR101","doi-asserted-by":"publisher","DOI":"10.1172\/JCI178628","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wu J, Najem H, Lin Y, Pang L, Khan F, et al. Dual targeting macrophages and microglia is a therapeutic vulnerability in models of PTEN-deficient glioblastoma. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI178628.","journal-title":"J Clin Invest"},{"issue":"26","key":"4715_CR102","doi-asserted-by":"publisher","first-page":"16359","DOI":"10.1021\/acsnano.4c01790","volume":"18","author":"F Branco","year":"2024","unstructured":"Branco F, Cunha J, Mendes M, Vitorino C, Sousa JJ. Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma. ACS Nano. 2024;18(26):16359\u201394.","journal-title":"ACS Nano"},{"issue":"6","key":"4715_CR103","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.7150\/thno.39560","volume":"10","author":"Y Xu","year":"2020","unstructured":"Xu Y, Wu H, Huang J, Qian W, Martinson DE, Ji B, et al. Probing and Enhancing Ligand-Mediated Active Targeting of Tumors Using Sub-5 nm Ultrafine Iron Oxide Nanoparticles. Theranostics. 2020;10(6):2479\u201394.","journal-title":"Theranostics"},{"issue":"1","key":"4715_CR104","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12951-023-01827-0","volume":"21","author":"N Zhang","year":"2023","unstructured":"Zhang N, Ru B, Hu J, Xu L, Wan Q, Liu W, et al. Recent advances of CREKA peptide-based nanoplatforms in biomedical applications. J Nanobiotechnol. 2023;21(1):77.","journal-title":"J Nanobiotechnol"},{"issue":"1\u20132","key":"4715_CR105","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijpharm.2014.03.012","volume":"466","author":"H Gao","year":"2014","unstructured":"Gao H, Zhang S, Yang Z, Cao S, Jiang X, Pang Z. In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide. Int J Pharm. 2014;466(1\u20132):8\u201317.","journal-title":"Int J Pharm"},{"issue":"23","key":"4715_CR106","doi-asserted-by":"publisher","first-page":"34158","DOI":"10.18632\/oncotarget.8926","volume":"7","author":"SL Hayward","year":"2016","unstructured":"Hayward SL, Wilson CL, Kidambi S. Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells. Oncotarget. 2016;7(23):34158\u201371.","journal-title":"Oncotarget"},{"issue":"9","key":"4715_CR107","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1039\/C9NA00056A","volume":"1","author":"CK Elechalawar","year":"2019","unstructured":"Elechalawar CK, Bhattacharya D, Ahmed MT, Gora H, Sridharan K, Chaturbedy P, et al. Dual targeting of folate receptor-expressing glioma tumor-associated macrophages and epithelial cells in the brain using a carbon nanosphere-cationic folate nanoconjugate. Nanoscale Adv. 2019;1(9):3555\u201367.","journal-title":"Nanoscale Adv"},{"issue":"1","key":"4715_CR108","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1080\/10717544.2022.2075986","volume":"29","author":"R Liang","year":"2022","unstructured":"Liang R, Wu C, Liu S, Zhao W. Targeting interleukin-13 receptor alpha2 (IL-13Ralpha2) for glioblastoma therapy with surface functionalized nanocarriers. Drug Deliv. 2022;29(1):1620\u201330.","journal-title":"Drug Deliv"},{"key":"4715_CR109","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.canlet.2017.06.024","volume":"403","author":"J Yang","year":"2017","unstructured":"Yang J, Yan J, Liu B. Targeting EGFRvIII for glioblastoma multiforme. Cancer Lett. 2017;403:224\u201330.","journal-title":"Cancer Lett"},{"issue":"2","key":"4715_CR110","doi-asserted-by":"publisher","first-page":"941","DOI":"10.7150\/thno.44948","volume":"11","author":"PE Saw","year":"2021","unstructured":"Saw PE, Xu X, Kang BR, Lee J, Lee YS, Kim C, et al. Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma. Theranostics. 2021;11(2):941\u201357.","journal-title":"Theranostics"},{"issue":"4","key":"4715_CR111","doi-asserted-by":"publisher","first-page":"510","DOI":"10.15171\/apb.2019.061","volume":"9","author":"S Khanyile","year":"2019","unstructured":"Khanyile S, Masamba P, Oyinloye BE, Mbatha LS, Kappo AP. Current Biochemical Applications and Future Prospects of Chlorotoxin in Cancer Diagnostics and Therapeutics. Adv Pharm Bull. 2019;9(4):510\u201320.","journal-title":"Adv Pharm Bull"},{"key":"4715_CR112","doi-asserted-by":"publisher","unstructured":"Lingasamy P, Posnograjeva K, Kopanchuk S, Tobi A, Rinken A, General IJ et al. PL1 Peptide Engages Acidic Surfaces on Tumor-Associated Fibronectin and Tenascin Isoforms to Trigger Cellular Uptake. Pharmaceutics. 2021;13(12):1998. https:\/\/doi.org\/10.3390\/pharmaceutics13121998","DOI":"10.3390\/pharmaceutics13121998"},{"issue":"29","key":"4715_CR113","doi-asserted-by":"publisher","first-page":"e2400502","DOI":"10.1002\/adma.202400502","volume":"36","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ma H, Li L, Sun C, Yu C, Wang L, et al. Dual-Targeted Novel Temozolomide Nanocapsules Encapsulating siPKM2 Inhibit Aerobic Glycolysis to Sensitize Glioblastoma to Chemotherapy. Adv Mater. 2024;36(29):e2400502.","journal-title":"Adv Mater"},{"key":"4715_CR114","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.drup.2024.101122","volume":"76","author":"Y Lan","year":"2024","unstructured":"Lan Y, Li X, Liu B, Lu J, Zuo B, Wang Y, et al. Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma. Drug Resist Updat. 2024;76:101122.","journal-title":"Drug Resist Updat"},{"key":"4715_CR115","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.actbio.2023.05.037","volume":"166","author":"M Sun","year":"2023","unstructured":"Sun M, Li Y, Zhang W, Gu X, Wen R, Zhang K, et al. Allomelanin-based biomimetic nanotherapeutics for orthotopic glioblastoma targeted photothermal immunotherapy. Acta Biomater. 2023;166:552\u201366.","journal-title":"Acta Biomater"},{"key":"4715_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.160181","author":"J Lin","year":"2025","unstructured":"Lin J, Sun Z, Huang Y, Liu Q, Shen M, Shao C, et al. Glioma stem cell membrane-camouflaged photothermal nanozyme for synergistic antitumor via dual-targeted drug delivery across blood-brain barrier. Chem Eng J. 2025. https:\/\/doi.org\/10.1016\/j.cej.2025.160181.","journal-title":"Chem Eng J"},{"key":"4715_CR117","doi-asserted-by":"publisher","first-page":"6999","DOI":"10.2147\/IJN.S466268","volume":"19","author":"M Li","year":"2024","unstructured":"Li M, Zhang X, Zhou Y, Chu Y, Shen J, Cai Y, et al. Near Infrared-Activatable Biomimetic Nanoplatform for Tumor-Specific Drug Release, Penetration and Chemo-Photothermal Synergistic Therapy of Orthotopic Glioblastoma. Int J Nanomed. 2024;19:6999\u20137014.","journal-title":"Int J Nanomed"},{"issue":"18","key":"4715_CR118","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.7150\/thno.26225","volume":"8","author":"L Hua","year":"2018","unstructured":"Hua L, Wang Z, Zhao L, Mao H, Wang G, Zhang K, et al. Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy. Theranostics. 2018;8(18):5088\u2013105.","journal-title":"Theranostics"},{"issue":"1","key":"4715_CR119","doi-asserted-by":"publisher","first-page":"19225","DOI":"10.1038\/s41598-024-69696-7","volume":"14","author":"A Balboni","year":"2024","unstructured":"Balboni A, Ailuno G, Baldassari S, Drava G, Petretto A, Grinovero N, et al. Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors. Sci Rep. 2024;14(1):19225.","journal-title":"Sci Rep"},{"issue":"9","key":"4715_CR120","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1021\/acs.nanolett.6b02786","volume":"16","author":"JY Zhu","year":"2016","unstructured":"Zhu JY, Zheng DW, Zhang MK, Yu WY, Qiu WX, Hu JJ, et al. Preferential Cancer Cell Self-Recognition and Tumor Self-Targeting by Coating Nanoparticles with Homotypic Cancer Cell Membranes. Nano Lett. 2016;16(9):5895\u2013901.","journal-title":"Nano Lett"},{"issue":"26","key":"4715_CR121","doi-asserted-by":"publisher","first-page":"31150","DOI":"10.1021\/acsami.3c03001","volume":"15","author":"Y Li","year":"2023","unstructured":"Li Y, Liu Y, Xu J, Chen D, Wu T, Cao Y. Macrophage-Cancer Hybrid Membrane-Camouflaged Nanoplatforms for HIF-1alpha Gene Silencing-Enhanced Sonodynamic Therapy of Glioblastoma. ACS Appl Mater Interfaces. 2023;15(26):31150\u20138.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"14","key":"4715_CR122","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1021\/acsnano.3c01428","volume":"17","author":"J Kuang","year":"2023","unstructured":"Kuang J, Rao ZY, Zheng DW, Kuang D, Huang QX, Pan T, et al. Nanoparticles Hitchhike on Monocytes for Glioblastoma Treatment after Low-Dose Radiotherapy. ACS Nano. 2023;17(14):13333\u201347.","journal-title":"ACS Nano"},{"key":"4715_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2024.102259","author":"Q Liu","year":"2024","unstructured":"Liu Q, Li X, Wang Y, Liu X, Cao Y, Zhang H, et al. Neutrophil hitchhiking for nanoparticle delivery to the central nervous system. Appl Mater Today. 2024. https:\/\/doi.org\/10.1016\/j.apmt.2024.102259.","journal-title":"Appl Mater Today"},{"issue":"2","key":"4715_CR124","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.apsb.2022.09.016","volume":"13","author":"Z Mi","year":"2023","unstructured":"Mi Z, Yao Q, Qi Y, Zheng J, Liu J, Liu Z, et al. Salmonella-mediated blood\u2013brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo\/bacterial glioma therapy. Acta Pharm Sin B. 2023;13(2):819\u201333.","journal-title":"Acta Pharm Sin B"},{"issue":"9","key":"4715_CR125","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2174\/1389200223666220627110049","volume":"23","author":"A Setia","year":"2022","unstructured":"Setia A, Sahu RK, Ray S, Widyowati R, Ekasari W, Saraf S. Advances in Hybrid Vesicular-based Drug Delivery Systems: Improved Biocompatibility, Targeting, Therapeutic Efficacy and Pharmacokinetics of Anticancer Drugs. Curr Drug Metab. 2022;23(9):757\u201380.","journal-title":"Curr Drug Metab"},{"key":"4715_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041257","author":"A Ou","year":"2023","unstructured":"Ou A, Wang Y, Zhang J, Huang Y. Living Cells and Cell-Derived Vesicles: A Trojan Horse Technique for Brain Delivery. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15041257.","journal-title":"Pharmaceutics"},{"issue":"13","key":"4715_CR127","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.7150\/thno.99257","volume":"14","author":"W Liu","year":"2024","unstructured":"Liu W, Cheng G, Cui H, Tian Z, Li B, Han Y, et al. Theoretical basis, state and challenges of living cell-based drug delivery systems. Theranostics. 2024;14(13):5152\u201383.","journal-title":"Theranostics"},{"issue":"23","key":"4715_CR128","doi-asserted-by":"publisher","first-page":"12846","DOI":"10.1073\/pnas.97.23.12846","volume":"97","author":"KS Aboody","year":"2000","unstructured":"Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A. 2000;97(23):12846\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4715_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/cells13070617","author":"SM Santillan-Guajan","year":"2024","unstructured":"Santillan-Guajan SM, Shahi MH, Castresana JS. Mesenchymal-Stem-Cell-Based Therapy against Gliomas. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13070617.","journal-title":"Cells"},{"issue":"2","key":"4715_CR130","doi-asserted-by":"publisher","first-page":"e22169","DOI":"10.1002\/ddr.22169","volume":"85","author":"M Wang","year":"2024","unstructured":"Wang M, Jin Z, Huang H, Cheng X, Zhang Q, Tang Y, et al. Neutrophil hitchhiking: Riding the drug delivery wave to treat diseases. Drug Dev Res. 2024;85(2):e22169.","journal-title":"Drug Dev Res"},{"key":"4715_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/polym12091906","author":"S Kang","year":"2020","unstructured":"Kang S, Lee S, Park S. iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery. Polymers (Basel). 2020. https:\/\/doi.org\/10.3390\/polym12091906.","journal-title":"Polymers (Basel)"},{"key":"4715_CR132","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fonc.2013.00216","volume":"3","author":"T Teesalu","year":"2013","unstructured":"Teesalu T, Sugahara KN, Ruoslahti E. Tumor-penetrating peptides. Front Oncol. 2013;3:216.","journal-title":"Front Oncol"},{"key":"4715_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32040203","author":"SM Varanasi","year":"2025","unstructured":"Varanasi SM, Gulani Y, Rachamala HK, Mukhopadhyay D, Angom RS. Neuropilin-1: a multifaceted target for cancer therapy. Curr Oncol. 2025. https:\/\/doi.org\/10.3390\/curroncol32040203.","journal-title":"Curr Oncol"},{"issue":"3","key":"4715_CR134","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1021\/acs.nanolett.6b03815","volume":"17","author":"S Sharma","year":"2017","unstructured":"Sharma S, Kotamraju VR, Molder T, Tobi A, Teesalu T, Ruoslahti E. Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth. Nano Lett. 2017;17(3):1356\u201364.","journal-title":"Nano Lett"},{"issue":"9","key":"4715_CR135","doi-asserted-by":"publisher","first-page":"e0137676","DOI":"10.1371\/journal.pone.0137676","volume":"10","author":"HB Wu","year":"2015","unstructured":"Wu HB, Wang Z, Wang QS, Han YJ, Wang M, Zhou WL, et al. Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma. PLoS ONE. 2015;10(9):e0137676.","journal-title":"PLoS ONE"},{"issue":"23","key":"4715_CR136","doi-asserted-by":"publisher","first-page":"26759","DOI":"10.1021\/acsami.1c04990","volume":"13","author":"MH Chan","year":"2021","unstructured":"Chan MH, Chen W, Li CH, Fang CY, Chang YC, Wei DH, et al. An Advanced In Situ Magnetic Resonance Imaging and Ultrasonic Theranostics Nanocomposite Platform: Crossing the Blood-Brain Barrier and Improving the Suppression of Glioblastoma Using Iron-Platinum Nanoparticles in Nanobubbles. ACS Appl Mater Interfaces. 2021;13(23):26759\u201369.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5\u20136","key":"4715_CR137","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/1061186X.2019.1567738","volume":"27","author":"LP Ganipineni","year":"2019","unstructured":"Ganipineni LP, Ucakar B, Joudiou N, Riva R, Jerome C, Gallez B, et al. Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma. J Drug Target. 2019;27(5\u20136):614\u201323.","journal-title":"J Drug Target"},{"issue":"6","key":"4715_CR138","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1021\/acsbiomaterials.8b01173","volume":"5","author":"ND Thorat","year":"2019","unstructured":"Thorat ND, Townely H, Brennan G, Parchur AK, Silien C, Bauer J, et al. Progress in Remotely Triggered Hybrid Nanostructures for Next-Generation Brain Cancer Theranostics. ACS Biomater Sci Eng. 2019;5(6):2669\u201387.","journal-title":"ACS Biomater Sci Eng"},{"issue":"10","key":"4715_CR139","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1021\/acs.biomac.4c00722","volume":"25","author":"M Ismail","year":"2024","unstructured":"Ismail M, Wang Y, Li Y, Liu J, Zheng M, Zou Y. Stimuli-Responsive Polymeric Nanocarriers Accelerate On-Demand Drug Release to Combat Glioblastoma. Biomacromolecules. 2024;25(10):6250\u201382.","journal-title":"Biomacromolecules"},{"key":"4715_CR140","doi-asserted-by":"publisher","first-page":"118841","DOI":"10.1016\/j.ijpharm.2019.118841","volume":"575","author":"Z Fang","year":"2020","unstructured":"Fang Z, Pan S, Gao P, Sheng H, Li L, Shi L, et al. Stimuli-responsive charge-reversal nano drug delivery system: The promising targeted carriers for tumor therapy. Int J Pharm. 2020;575:118841.","journal-title":"Int J Pharm"},{"issue":"9","key":"4715_CR141","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.1021\/acsbiomaterials.4c00388","volume":"10","author":"XP Li","year":"2024","unstructured":"Li XP, Hou DY, Wu JC, Zhang P, Wang YZ, Lv MY, et al. Stimuli-Responsive Nanomaterials for Tumor Immunotherapy. ACS Biomater Sci Eng. 2024;10(9):5474\u201395.","journal-title":"ACS Biomater Sci Eng"},{"issue":"2","key":"4715_CR142","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1021\/acs.biomac.9b01578","volume":"21","author":"W Yin","year":"2020","unstructured":"Yin W, Ke W, Lu N, Wang Y, Japir A, Mohammed F, et al. Glutathione and Reactive Oxygen Species Dual-Responsive Block Copolymer Prodrugs for Boosting Tumor Site-Specific Drug Release and Enhanced Antitumor Efficacy. Biomacromolecules. 2020;21(2):921\u20139.","journal-title":"Biomacromolecules"},{"key":"4715_CR143","doi-asserted-by":"publisher","unstructured":"Liu ZS, Wen J, Huang CY, Zhang PW, Miao YL, Cheng H et al. Nanomedicines Based on Responsive Nanocarriers for Cancer Therapy. Adv Ther. 2023;7(2):2300223. https:\/\/doi.org\/10.1002\/adtp.202300223","DOI":"10.1002\/adtp.202300223"},{"issue":"12","key":"4715_CR144","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1039\/D3CS00001J","volume":"52","author":"N Kang","year":"2023","unstructured":"Kang N, Son S, Min S, Hong H, Kim C, An J, et al. Stimuli-responsive ferroptosis for cancer therapy. Chem Soc Rev. 2023;52(12):3955\u201372.","journal-title":"Chem Soc Rev"},{"key":"4715_CR145","doi-asserted-by":"publisher","unstructured":"Zhang X, Soh S. Performing Logical Operations with Stimuli-Responsive Building Blocks. Adv Mater. 2017;29(18):10.1002\/adma.201606483. https:\/\/doi.org\/10.1002\/adma.201606483","DOI":"10.1002\/adma.201606483"},{"issue":"15","key":"4715_CR146","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1021\/acs.langmuir.0c00460","volume":"36","author":"Q Hao","year":"2020","unstructured":"Hao Q, Kang Y, Xu JF, Zhang X. pH\/ROS Dual-Responsive Supramolecular Vesicles Fabricated by Carboxylated Pillar[6]arene-Based Host-Guest Recognition and Phenylboronic Acid Pinacol Ester Derivative. Langmuir. 2020;36(15):4080\u20137.","journal-title":"Langmuir"},{"key":"4715_CR147","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.actbio.2024.11.035","volume":"192","author":"W Xing","year":"2025","unstructured":"Xing W, Li T, Yang G, Wu S, Pang B, Xu Y, et al. Thermo-responsive gold nanorod vesicles for combined NIR-II photothermal therapy and chemotherapy of solid tumors. Acta Biomater. 2025;192:353\u201365.","journal-title":"Acta Biomater"},{"issue":"22","key":"4715_CR148","doi-asserted-by":"publisher","first-page":"e2008802","DOI":"10.1002\/adma.202008802","volume":"33","author":"M Zhang","year":"2021","unstructured":"Zhang M, Wang W, Mohammadniaei M, Zheng T, Zhang Q, Ashley J, et al. Upregulating Aggregation-Induced-Emission Nanoparticles with Blood-Tumor-Barrier Permeability for Precise Photothermal Eradication of Brain Tumors and Induction of Local Immune Responses. Adv Mater. 2021;33(22):e2008802.","journal-title":"Adv Mater"},{"issue":"10","key":"4715_CR149","doi-asserted-by":"publisher","first-page":"e2410992","DOI":"10.1002\/adma.202410992","volume":"37","author":"T Xiong","year":"2025","unstructured":"Xiong T, Chen Y, Peng Q, Zhou X, Li M, Lu S, et al. Heterodimeric Photosensitizer as Radical Generators to Promoting Type I Photodynamic Conversion for Hypoxic Tumor Therapy. Adv Mater. 2025;37(10):e2410992.","journal-title":"Adv Mater"},{"issue":"9","key":"4715_CR150","doi-asserted-by":"publisher","first-page":"e202420643","DOI":"10.1002\/anie.202420643","volume":"64","author":"J Zhuang","year":"2025","unstructured":"Zhuang J, Liu S, Li B, Li Z, Wu C, Xu D, et al. Electron Transfer Mediator Modulates Type II Porphyrin-Based Metal-Organic Framework Photosensitizers for Type I Photodynamic Therapy. Angew Chem Int Ed Engl. 2025;64(9):e202420643.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4715_CR151","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.actbio.2025.01.016","volume":"193","author":"W Cheng","year":"2025","unstructured":"Cheng W, Duan Z, Chen H, Wang Y, Wang C, Pan Y, et al. Macrophage membrane-camouflaged pure-drug nanomedicine for synergistic chemo- and interstitial photodynamic therapy against glioblastoma. Acta Biomater. 2025;193:392\u2013405.","journal-title":"Acta Biomater"},{"issue":"30","key":"4715_CR152","doi-asserted-by":"publisher","first-page":"26648","DOI":"10.1021\/acsami.9b08318","volume":"11","author":"S Del Sol-Fernandez","year":"2019","unstructured":"Del Sol-Fernandez S, Portilla-Tundidor Y, Gutierrez L, Odio OF, Reguera E, Barber DF, et al. Flower-like Mn-Doped Magnetic Nanoparticles Functionalized with alpha(v)beta(3)-Integrin-Ligand to Efficiently Induce Intracellular Heat after Alternating Magnetic Field Exposition, Triggering Glioma Cell Death. ACS Appl Mater Interfaces. 2019;11(30):26648\u201363.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"23","key":"4715_CR153","doi-asserted-by":"publisher","first-page":"27465","DOI":"10.1021\/acsanm.4c05452","volume":"7","author":"A Maier","year":"2024","unstructured":"Maier A, Jia Q, Shukla K, Dugulan AI, Hagedoorn PL, van Oossanen R, et al. Enhancing Magnetic Hyperthermia Efficiency in Pd\/Fe-Oxide Hybrid Nanoparticles through Mn-Doping. ACS Appl Nano Mater. 2024;7(23):27465\u201375.","journal-title":"ACS Appl Nano Mater"},{"key":"4715_CR154","doi-asserted-by":"publisher","unstructured":"Persano S, Vicini F, Poggi A, Fernandez JLC, Rizzo GMR, Gavilan H et al. Elucidating the Innate Immunological Effects of Mild Magnetic Hyperthermia on U87 Human Glioblastoma Cells: An In Vitro Study. Pharmaceutics. 2021;13(10):1668. https:\/\/doi.org\/10.3390\/pharmaceutics13101668","DOI":"10.3390\/pharmaceutics13101668"},{"issue":"1","key":"4715_CR155","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1215\/S1152851703000188","volume":"6","author":"SL Chua","year":"2004","unstructured":"Chua SL, Rosenthal MA, Wong SS, Ashley DM, Woods AM, Dowling A, et al. Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme. Neuro Oncol. 2004;6(1):38\u201343.","journal-title":"Neuro Oncol"},{"issue":"1","key":"4715_CR156","doi-asserted-by":"publisher","first-page":"100365","DOI":"10.1016\/j.esmoop.2021.100365","volume":"7","author":"B Kasenda","year":"2022","unstructured":"Kasenda B, Konig D, Manni M, Ritschard R, Duthaler U, Bartoszek E, et al. Targeting immunoliposomes to EGFR-positive glioblastoma. ESMO Open. 2022;7(1):100365.","journal-title":"ESMO Open"},{"issue":"1","key":"4715_CR157","first-page":"vdae186","volume":"6","author":"C Dmello","year":"2024","unstructured":"Dmello C, Brenner A, Piccioni D, Wen PY, Drappatz J, Mrugala M, et al. Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma. Neurooncol Adv. 2024;6(1):vdae186.","journal-title":"Neurooncol Adv"},{"issue":"Suppl 5","key":"4715_CR158","doi-asserted-by":"publisher","first-page":"v163","DOI":"10.1093\/neuonc\/nou265.21","volume":"16","author":"BM Kerklaan","year":"2014","unstructured":"Kerklaan BM, Jager A, Aftimos P, Dieras V, Altintas S, Anders C, et al. NT-23: PHASE 1\/2A STUDY OF GLUTATHIONE PEGYLATED LIPOSOMAL DOXORUBICIN (2B3-101) IN BREAST CANCER PATIENTS WITH BRAIN METASTASES (BCBM) OR RECURRENT HIGH GRADE GLIOMAS (HGG). Neuro Oncol. 2014;16(Suppl 5):v163.","journal-title":"Neuro Oncol"},{"issue":"1","key":"4715_CR159","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s41467-024-45818-7","volume":"15","author":"A Carpentier","year":"2024","unstructured":"Carpentier A, Stupp R, Sonabend AM, Dufour H, Chinot O, Mathon B, et al. Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I\/II clinical trial. Nat Commun. 2024;15(1):1650.","journal-title":"Nat Commun"},{"issue":"1","key":"4715_CR160","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12885-023-10829-y","volume":"23","author":"E Thivat","year":"2023","unstructured":"Thivat E, Casile M, Moreau J, Molnar I, Dufort S, Seddik K, et al. Phase I\/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol). BMC Cancer. 2023;23(1):344.","journal-title":"BMC Cancer"},{"key":"4715_CR161","first-page":"100833","volume":"48","author":"J Biau","year":"2024","unstructured":"Biau J, Durando X, Boux F, Molnar I, Moreau J, Leyrat B, et al. NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution. Clin Transl Radiat Oncol. 2024;48:100833.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"8","key":"4715_CR162","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1080\/02656736.2018.1430867","volume":"34","author":"K Mahmoudi","year":"2018","unstructured":"Mahmoudi K, Bouras A, Bozec D, Ivkov R, Hadjipanayis C. Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy\u2019s history, efficacy and application in humans. Int J Hyperth. 2018;34(8):1316\u201328.","journal-title":"Int J Hyperth"},{"key":"4715_CR163","doi-asserted-by":"publisher","first-page":"9597","DOI":"10.2147\/IJN.S531451","volume":"20","author":"K Wang","year":"2025","unstructured":"Wang K, Sun J, Zhao H, Wang F, Zhang X, Zhao X, et al. Advances and Challenges in Nano-Delivery Systems for Glioblastoma Treatment: A Comprehensive Review. Int J Nanomed. 2025;20:9597\u2013620.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4715_CR164","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.1038\/s41467-023-41694-9","volume":"14","author":"I Noorani","year":"2023","unstructured":"Noorani I, de la Rosa J. Breaking barriers for glioblastoma with a path to enhanced drug delivery. Nat Commun. 2023;14(1):5909.","journal-title":"Nat Commun"},{"key":"4715_CR165","doi-asserted-by":"publisher","unstructured":"Bartusik-Aebisher D, Rudy I, Pieta K, Aebisher D. Nano-Based Technology in Glioblastoma. Molecules. 2025;30(17):3485. https:\/\/doi.org\/10.3390\/molecules30173485","DOI":"10.3390\/molecules30173485"},{"issue":"Suppl 2","key":"4715_CR166","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1093\/neuonc\/nou354","volume":"17","author":"MA Vogelbaum","year":"2015","unstructured":"Vogelbaum MA, Aghi MK. Convection-enhanced delivery for the treatment of glioblastoma. Neuro Oncol. 2015;17(Suppl 2):ii3\u20138.","journal-title":"Neuro Oncol"},{"issue":"22","key":"4715_CR167","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202300029","volume":"19","author":"C Martins","year":"2023","unstructured":"Martins C, Araujo M, Malfanti A, Pacheco C, Smith SJ, Ucakar B, et al. Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting. Small. 2023;19(22):e2300029.","journal-title":"Small"},{"key":"4715_CR168","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jconrel.2023.11.033","volume":"365","author":"R Wang","year":"2024","unstructured":"Wang R, Wang X, Zhao H, Li N, Li J, Zhang H, et al. Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma. J Control Release. 2024;365:331\u201347.","journal-title":"J Control Release"},{"issue":"1","key":"4715_CR169","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12951-024-02531-3","volume":"22","author":"X Chen","year":"2024","unstructured":"Chen X, Zheng Y, Zhang Q, Chen Q, Chen Z, Wu D. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma. J Nanobiotechnol. 2024;22(1):264.","journal-title":"J Nanobiotechnol"},{"key":"4715_CR170","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201808601","author":"L Liu","year":"2019","unstructured":"Liu L, Chen Q, Wen L, Li C, Qin H, Xing D. Photoacoustic therapy for precise eradication of glioblastoma with a tumor site blood\u2013brain barrier permeability upregulating nanoparticle. Advanced Functional Materials. 2019. https:\/\/doi.org\/10.1002\/adfm.201808601.","journal-title":"Advanced Functional Materials"},{"issue":"48","key":"4715_CR171","doi-asserted-by":"publisher","first-page":"e2409753","DOI":"10.1002\/advs.202409753","volume":"11","author":"L Yi","year":"2024","unstructured":"Yi L, Zhang Z, Zhou W, Zhang Y, Hu Y, Guo A, et al. BRD4 Degradation Enhanced Glioma Sensitivity to Temozolomide by Regulating Notch1 via Glu-Modified GSH-Responsive Nanoparticles. Adv Sci (Weinh). 2024;11(48):e2409753.","journal-title":"Adv Sci (Weinh)"},{"issue":"30","key":"4715_CR172","doi-asserted-by":"publisher","first-page":"e2400630","DOI":"10.1002\/smll.202400630","volume":"20","author":"W Zhuo","year":"2024","unstructured":"Zhuo W, Wang W, Zhou W, Duan Z, He S, Zhang X, et al. A Targeted and Responsive Nanoprodrug Delivery System for Synergistic Glioma Chemotherapy. Small. 2024;20(30):e2400630.","journal-title":"Small"},{"issue":"4","key":"4715_CR173","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7150\/ntno.38954","volume":"3","author":"C Liu","year":"2019","unstructured":"Liu C, Zhao Z, Gao H, Rostami I, You Q, Jia X, et al. Enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly(amidoamine) dendrimer for the therapy of gliomas. Nanotheranostics. 2019;3(4):311\u201330.","journal-title":"Nanotheranostics"},{"key":"4715_CR174","doi-asserted-by":"publisher","first-page":"101067","DOI":"10.1016\/j.mtbio.2024.101067","volume":"26","author":"J Lin","year":"2024","unstructured":"Lin J, Lin Z, Liu L, Lin W, Xie X, Zhang X. Enhancing glioma-specific drug delivery through self-assembly of macrophage membrane and targeted polymer assisted by low-frequency ultrasound irradiation. Mater Today Bio. 2024;26:101067.","journal-title":"Mater Today Bio"},{"issue":"14","key":"4715_CR175","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.7150\/thno.46468","volume":"10","author":"C Brighi","year":"2020","unstructured":"Brighi C, Reid L, Genovesi LA, Kojic M, Millar A, Bruce Z, et al. Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity. Theranostics. 2020;10(14):6361\u201371.","journal-title":"Theranostics"},{"key":"4715_CR176","doi-asserted-by":"publisher","first-page":"115702","DOI":"10.1016\/j.addr.2025.115702","volume":"227","author":"C Ferreira","year":"2025","unstructured":"Ferreira C, Sarmento B, Martins C. In vitro models of the interplay between glioblastoma and blood-brain barrier for stratifying drug efficacy. Adv Drug Deliv Rev. 2025;227:115702.","journal-title":"Adv Drug Deliv Rev"},{"key":"4715_CR177","unstructured":"Garcia C, Fau - Dubois LG. Dubois Lg Fau - Xavier AL, Xavier Al Fau - Geraldo LH, Geraldo Lh Fau - da Fonseca ACC, da Fonseca Ac Fau - Correia AH, Correia Ah Fau - Meirelles F, The orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblastoma-microenvironment interactions in a non-immunosuppressed mouse model. (1471\u20132407 (Electronic))."},{"issue":"10","key":"4715_CR178","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nnano.2013.181","volume":"8","author":"S Tenzer","year":"2013","unstructured":"Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol. 2013;8(10):772\u201381.","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"4715_CR179","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nnano.2016.269","volume":"12","author":"F Chen","year":"2017","unstructured":"Chen F, Wang G, Griffin JI, Brenneman B, Banda NK, Holers VM, et al. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. Nat Nanotechnol. 2017;12(4):387\u201393.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"4715_CR180","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11095-019-2747-8","volume":"37","author":"T Ding","year":"2019","unstructured":"Ding T, Sun J. Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q. Pharm Res. 2019;37(1):10.","journal-title":"Pharm Res"},{"issue":"12","key":"4715_CR181","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/nnano.2012.207","volume":"7","author":"MP Monopoli","year":"2012","unstructured":"Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol. 2012;7(12):779\u201386.","journal-title":"Nat Nanotechnol"},{"issue":"9","key":"4715_CR182","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941\u201351.","journal-title":"Nat Biotechnol"},{"key":"4715_CR183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","volume":"14","author":"A Albanese","year":"2012","unstructured":"Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1\u201316.","journal-title":"Annu Rev Biomed Eng"},{"issue":"5","key":"4715_CR184","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2217\/17435889.3.5.703","volume":"3","author":"M Longmire","year":"2008","unstructured":"Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomed (Lond). 2008;3(5):703\u201317.","journal-title":"Nanomed (Lond)"},{"issue":"5761","key":"4715_CR185","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.1114397","volume":"311","author":"A Nel","year":"2006","unstructured":"Nel A, Xia T, M\u00e4dler L, Li N. Toxic Potential of Materials at the Nanolevel. Science. 2006;311(5761):622\u20137.","journal-title":"Science"},{"issue":"5","key":"4715_CR186","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/wnan.103","volume":"2","author":"AM Schrand","year":"2010","unstructured":"Schrand AM, Rahman MF, Hussain SM, Schlager JJ, Smith DA, Syed AF. Metal-based nanoparticles and their toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2(5):544\u201368.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"4715_CR187","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva C, Praca C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release. 2016;235:34\u201347.","journal-title":"J Control Release"},{"issue":"11","key":"4715_CR188","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nmat3776","volume":"12","author":"S Mura","year":"2013","unstructured":"Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12(11):991\u20131003.","journal-title":"Nat Mater"},{"issue":"1","key":"4715_CR189","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37(1):13\u201325.","journal-title":"Neurobiol Dis"},{"issue":"12","key":"4715_CR190","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19(12):1584\u201396.","journal-title":"Nat Med"},{"issue":"18","key":"4715_CR191","doi-asserted-by":"publisher","first-page":"21301","DOI":"10.1021\/acsami.2c00600","volume":"14","author":"M Li","year":"2022","unstructured":"Li M, Liu C, Yin J, Liu G, Chen D. Single-Step Synthesis of Highly Tunable Multifunctional Nanoliposomes for Synergistic Cancer Therapy. ACS Appl Mater Interfaces. 2022;14(18):21301\u20139.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"4715_CR192","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","volume":"12","author":"S Dordevic","year":"2022","unstructured":"Dordevic S, Gonzalez MM, Conejos-Sanchez I, Carreira B, Pozzi S, Acurcio RC, et al. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res. 2022;12(3):500\u201325.","journal-title":"Drug Deliv Transl Res"},{"issue":"36","key":"4715_CR193","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.2174\/0929867328666210406115529","volume":"28","author":"I Csoka","year":"2021","unstructured":"Csoka I, Ismail R, Jojart-Laczkovich O, Pallagi E. Regulatory Considerations, Challenges and Risk-based Approach in Nanomedicine Development. Curr Med Chem. 2021;28(36):7461\u201376.","journal-title":"Curr Med Chem"},{"issue":"11","key":"4715_CR194","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","volume":"19","author":"P Joyce","year":"2024","unstructured":"Joyce P, Allen CJ, Alonso MJ, Ashford M, Bradbury MS, Germain M, et al. A translational framework to DELIVER nanomedicines to the clinic. Nat Nanotechnol. 2024;19(11):1597\u2013611.","journal-title":"Nat Nanotechnol"},{"key":"4715_CR195","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17020142","author":"M Horta","year":"2025","unstructured":"Horta M, Soares P, Leite Pereira C, Lima RT. Emerging approaches in glioblastoma treatment: modulating the extracellular matrix through nanotechnology. Pharmaceutics. 2025. https:\/\/doi.org\/10.3390\/pharmaceutics17020142.","journal-title":"Pharmaceutics"},{"key":"4715_CR196","first-page":"55","volume":"38","author":"Q Guo","year":"2024","unstructured":"Guo Q, Qian ZM. Macrophage based drug delivery: key challenges and strategies. Bioact Mater. 2024;38:55\u201372.","journal-title":"Bioact Mater"},{"issue":"1","key":"4715_CR197","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12974-025-03435-1","volume":"22","author":"E Slowikowski","year":"2025","unstructured":"Slowikowski E, Willems C, Lemes RMR, Schuermans S, Berghmans N, Rocha RPF, et al. A central role for CCR2 in monocyte recruitment and blood-brain barrier disruption during Usutu virus encephalitis. J Neuroinflammation. 2025;22(1):107.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"4715_CR198","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2217\/nnm-2017-0266","volume":"13","author":"C Wang","year":"2018","unstructured":"Wang C, Li K, Li T, Chen Z, Wen Y, Liu X, et al. Monocyte-mediated chemotherapy drug delivery in glioblastoma. Nanomed (Lond). 2018;13(2):157\u201378.","journal-title":"Nanomed (Lond)"},{"issue":"1","key":"4715_CR199","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1038\/s41467-023-37872-4","volume":"14","author":"Y Chang","year":"2023","unstructured":"Chang Y, Cai X, Syahirah R, Yao Y, Xu Y, Jin G, et al. CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy. Nat Commun. 2023;14(1):2266.","journal-title":"Nat Commun"},{"issue":"1","key":"4715_CR200","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41467-025-56097-1","volume":"16","author":"SH Yoon","year":"2025","unstructured":"Yoon SH, Kim CY, Lee E, Lee C, Lee KS, Lee J, et al. Microglial NLRP3-gasdermin D activation impairs blood-brain barrier integrity through interleukin-1beta-independent neutrophil chemotaxis upon peripheral inflammation in mice. Nat Commun. 2025;16(1):699.","journal-title":"Nat Commun"},{"key":"4715_CR201","doi-asserted-by":"publisher","first-page":"1083242","DOI":"10.3389\/fmed.2023.1083242","volume":"10","author":"A Shafqat","year":"2023","unstructured":"Shafqat A, Noor Eddin A, Adi G, Al-Rimawi M, Abdul Rab S, Abu-Shaar M, et al. Neutrophil extracellular traps in central nervous system pathologies: A mini review. Front Med (Lausanne). 2023;10:1083242.","journal-title":"Front Med (Lausanne)"},{"key":"4715_CR202","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jconrel.2020.10.037","volume":"329","author":"Y Takayama","year":"2021","unstructured":"Takayama Y, Kusamori K, Tsukimori C, Shimizu Y, Hayashi M, Kiyama I, et al. Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy. J Control Release. 2021;329:1090\u2013101.","journal-title":"J Control Release"},{"issue":"184","key":"4715_CR203","doi-asserted-by":"publisher","first-page":"184ra59","DOI":"10.1126\/scitranslmed.3005365","volume":"5","author":"KS Aboody","year":"2013","unstructured":"Aboody KS, Najbauer J, Metz MZ, D\u2019Apuzzo M, Gutova M, Annala AJ, et al. Neural stem cell-mediated enzyme\/prodrug therapy for glioma: preclinical studies. Sci Transl Med. 2013;5(184):184ra59.","journal-title":"Sci Transl Med"},{"issue":"13","key":"4715_CR204","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/jnci\/djt141","volume":"105","author":"AU Ahmed","year":"2013","unstructured":"Ahmed AU, Thaci B, Tobias AL, Auffinger B, Zhang L, Cheng Y, et al. A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy. J Natl Cancer Inst. 2013;105(13):968\u201377.","journal-title":"J Natl Cancer Inst"},{"issue":"17","key":"4715_CR205","doi-asserted-by":"publisher","first-page":"7210","DOI":"10.1158\/0008-5472.CAN-07-6752","volume":"68","author":"V Fogal","year":"2008","unstructured":"Fogal V, Zhang L, Krajewski S, Ruoslahti E. Mitochondrial\/cell-surface protein p32\/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res. 2008;68(17):7210\u20138.","journal-title":"Cancer Res"},{"issue":"1","key":"4715_CR206","doi-asserted-by":"publisher","first-page":"5809","DOI":"10.1038\/s41598-020-62760-y","volume":"10","author":"P Lingasamy","year":"2020","unstructured":"Lingasamy P, Tobi A, Kurm K, Kopanchuk S, Sudakov A, Salumae M, et al. Tumor-penetrating peptide for systemic targeting of Tenascin-C. Sci Rep. 2020;10(1):5809.","journal-title":"Sci Rep"},{"issue":"10","key":"4715_CR207","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1021\/bi101662j","volume":"50","author":"N Haspel","year":"2011","unstructured":"Haspel N, Zanuy D, Nussinov R, Teesalu T, Ruoslahti E, Aleman C. Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach. Biochemistry. 2011;50(10):1755\u201362.","journal-title":"Biochemistry"},{"key":"4715_CR208","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1126\/scitranslmed.abb3945","volume":"13","author":"P Kumthekar","year":"2021","unstructured":"Kumthekar P, Ko CH, Paunesku T, Dixit K, Sonabend AM, Bloch O, et al. A first-in-human phase 0 clinical study of RNA interference\u2013based spherical nucleic acids in patients with recurrent glioblastoma. Sci Transl Med. 2021;13:584.","journal-title":"Sci Transl Med"},{"issue":"2","key":"4715_CR209","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/14712598.2022.2157718","volume":"23","author":"ML Varela","year":"2023","unstructured":"Varela ML, Comba A, Faisal SM, Argento A, Franson A, Barissi MN, et al. Gene Therapy for High Grade Glioma: The Clinical Experience. Expert Opin Biol Ther. 2023;23(2):145\u201361.","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"4715_CR210","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00280-017-3247-3","volume":"79","author":"JL Clarke","year":"2017","unstructured":"Clarke JL, Molinaro AM, Cabrera JR, DeSilva AA, Rabbitt JE, Prey J, et al. A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma. Cancer Chemother Pharmacol. 2017;79(3):603\u201310.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"4715_CR211","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/s41467-025-57263-1","volume":"16","author":"AJ Brenner","year":"2025","unstructured":"Brenner AJ, Patel T, Bao A, Phillips WT, Michalek JE, Youssef M, et al. Convection enhanced delivery of Rhenium ((186)Re) Obisbemeda ((186)RNL) in recurrent glioma: a multicenter, single arm, phase 1 clinical trial. Nat Commun. 2025;16(1):2079.","journal-title":"Nat Commun"},{"key":"4715_CR212","doi-asserted-by":"publisher","DOI":"10.3390\/ph17030300","author":"B Rodriguez","year":"2024","unstructured":"Rodriguez B, Rivera D, Zhang JY, Brown C, Young T, Williams T, et al. Magnetic hyperthermia therapy for high-grade glioma: a state-of-the-art review. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17030300.","journal-title":"Pharmaceuticals (Basel)"},{"key":"4715_CR213","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jconrel.2022.03.019","volume":"345","author":"M Farshbaf","year":"2022","unstructured":"Farshbaf M, Mojarad-Jabali S, Hemmati S, Khosroushahi AY, Motasadizadeh H, Zarebkohan A, et al. Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers. J Control Release. 2022;345:371\u201384.","journal-title":"J Control Release"},{"issue":"2","key":"4715_CR214","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/acsami.8b18664","volume":"11","author":"S Fu","year":"2019","unstructured":"Fu S, Liang M, Wang Y, Cui L, Gao C, Chu X, et al. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma. ACS Appl Mater Interfaces. 2019;11(2):1841\u201354.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4715_CR215","doi-asserted-by":"publisher","first-page":"114093","DOI":"10.1016\/j.ejmech.2021.114093","volume":"230","author":"J Lu","year":"2022","unstructured":"Lu J, Li R, Mu B, Peng Y, Zhao Y, Shi Y, et al. Multiple targeted doxorubicin-lonidamine liposomes modified with p-hydroxybenzoic acid and triphenylphosphonium to synergistically treat glioma. Eur J Med Chem. 2022;230:114093.","journal-title":"Eur J Med Chem"},{"issue":"3","key":"4715_CR216","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/1061186X.2020.1841214","volume":"29","author":"Z Jin","year":"2021","unstructured":"Jin Z, Piao L, Sun G, Lv C, Jing Y, Jin R. Dual functional nanoparticles efficiently across the blood-brain barrier to combat glioblastoma via simultaneously inhibit the PI3K pathway and NKG2A axis. J Drug Target. 2021;29(3):323\u201335.","journal-title":"J Drug Target"},{"key":"4715_CR217","doi-asserted-by":"publisher","first-page":"122702","DOI":"10.1016\/j.biomaterials.2024.122702","volume":"311","author":"W Cheng","year":"2024","unstructured":"Cheng W, Ren W, Ye P, He L, Bao D, Yue T, et al. Camouflaging nanoreactor traverse the blood-brain barrier to catalyze redox cascade for synergistic therapy of glioblastoma. Biomaterials. 2024;311:122702.","journal-title":"Biomaterials"},{"issue":"1","key":"4715_CR218","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1038\/s41467-023-40280-3","volume":"14","author":"Y Zou","year":"2023","unstructured":"Zou Y, Sun Y, Wang Y, Zhang D, Yang H, Wang X, et al. Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment. Nat Commun. 2023;14(1):4557.","journal-title":"Nat Commun"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04715-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04715-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04715-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:03:04Z","timestamp":1789005784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04715-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":218,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4715"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04715-5","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"850"}}